Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially a…
Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially a…
Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products, Swissmedic, has approved…
Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first nine months of 2023 and busi…
. As a subsidiary of AOK Bayern and AOK PLUS, kubus IT is responsible for IT operations for 17,000 AOK users. Arvato S…
A number of contracts of varying size have been signed Deliveries to start immediately aiming to ensure a rapid resp…
The global injectable drugs delivery market Size is expected to hit around US$ 1,223.6 billion by 2030 with a compound a…
Bavarian Nordic A/S (OMX: BAVA) announced today that the European Medicines Agency (EMA) has granted access to its prior…
HERA has ordered 110,000 doses of the Company’s MVA-BN smallpox/monkeypox vaccine for donation to Member States Deliveri…
Global Preventive Medicine market is highly fragmented because of existence of multiple members providing these services…
Deliveries to start immediately aiming to ensure a rapid response to the current monkeypox outbreak Company upgrades its…